Throughout the pandemic, U.S. drug manufacturers have taken center stage in combatting the pandemic at home. The industry has received accolades for its response to Operation Warp Speed claiming 279,000…
Read More
Systemness in Healthcare: Pipedream or Possible? Since February 26, the U.S. public’s attention has shifted from the pandemic to the Russian Federation’s invasion of Ukraine and its potential fallout on…
President Biden will deliver the State of the Union address tomorrow. Its focus will be the Russia Federation invasion of Ukraine, inflation and lessons learned from the pandemic thus far….
This week, all eyes will be on Ukraine, Europe’s poorest country. Since becoming an independent state in 1991 after separating from the Soviet Union, Ukraine has failed to invest in…
The value agenda in U.S. healthcare is transitioning to version 3.0. While the aim of replacing fee-for-service incentives remains the same, the next version will be decidedly different. Value Agenda…
January is almost in the books. It closes as Covid-19 hospitalizations slow in the U.S and the rolling 7-day average of daily deaths, a lag indicator, continues to rise. The…
“As 2022 begins, every healthcare operator, investor and regulator is calibrating adjustments to the omicron pandemic, inflation, political dysfunction and influx of private investment in the health system. What’s also needed…
The 40th Annual JP Morgan Healthcare Conference the second week of January was a virtual event for the second year in a row. It’s the perennial Woodstock where healthcare investors…
The plight of hospitals during the omicron pandemic is prominent in news coverage. Workforce shortages and bed capacity issues grab headlines, especially in regions where the omicron wave is surging….
Effective last Sunday, the No Surprises Act (NSA) passed by Congress in December 2020, became law. It protects consumers against surprise bills from out-of-network hospitals and physicians which apply to…
